)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
ST Pharm
ST Pharm (237690) investor relations material
ST Pharm Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary27 Oct, 2026
Executive summary
Q3 2026 revenue rose 19.1% YoY to KRW 97.6bn and operating profit increased 6.6% to KRW 15.7bn; net income fell 94.8% to KRW 0.9bn, mainly on FX losses.
Financial highlights
Gross profit was KRW 36.8bn vs. KRW 37.0bn YoY; cost of goods sold rose to KRW 60.8bn from KRW 44.9bn.
SG&A declined 5.3% YoY to KRW 21.1bn, while R&D expenses increased 21.0% to KRW 8.1bn.
Outlook and guidance
Small Molecule CDMO expects additional batches in 2027; further margin improvement is anticipated as optimization continues.
Commercial project growth supported Q3 sales; secured co-development projects from two new clients, including SmartCap, LNP and optimization services.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ST Pharm
- 1Q26 profit surged as oligo clinical sales and a $329m backlog supported growth.237690
Macquarie Asia Conference 2026 presentation - Oligo CDMO growth lifted 2Q25 revenue and margins as backlog reached $240M.237690Global Investors Conference 2025 presentation
- Oligo CDMO scale-up pairs RNA platform growth with biosimilar and drug pipeline catalysts.237690Korea Investors Conference 2025 presentation
- Oligo CDMO scale-up and RNA platforms anchor growth amid 2Q revenue pressure.237690Korea Investment Week 2024 presentation
- Oligo growth and backlog support the outlook amid lower FY revenue.237690Q4 2024
- Oligo CDMO lifted Q3 revenue 32.7% and operating profit 141.6% YoY.237690Q3 2025
- Oligo growth and capacity expansion contrasted with lower net income and customer concentration risks.237690Q1 2025
- Q3 sales grew, but CRO headwinds cut operating profit as oligo expansion underpinned the outlook.237690Q3 2024
- Q2 revenue grew 52.8% YoY as operating profit rebounded and oligonucleotide CDMO expanded.237690Q2 2025
Next ST Pharm earnings date
Q4 20265 Feb, 2027
ST Pharm
Next ST Pharm earnings date
Q4 20265 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)